ATE485033T1 - Pharmazeutische formulierung von nitrooxy- derivaten von nsar - Google Patents

Pharmazeutische formulierung von nitrooxy- derivaten von nsar

Info

Publication number
ATE485033T1
ATE485033T1 AT06777502T AT06777502T ATE485033T1 AT E485033 T1 ATE485033 T1 AT E485033T1 AT 06777502 T AT06777502 T AT 06777502T AT 06777502 T AT06777502 T AT 06777502T AT E485033 T1 ATE485033 T1 AT E485033T1
Authority
AT
Austria
Prior art keywords
nsaids
pharmaceutical formulation
nitrooxy derivatives
nitrooxy
derivatives
Prior art date
Application number
AT06777502T
Other languages
English (en)
Inventor
Ulla Gasslander
Christina Holmberg
Original Assignee
Nicox Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox Sa filed Critical Nicox Sa
Application granted granted Critical
Publication of ATE485033T1 publication Critical patent/ATE485033T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT06777502T 2005-07-26 2006-06-29 Pharmazeutische formulierung von nitrooxy- derivaten von nsar ATE485033T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05106854 2005-07-26
PCT/EP2006/063672 WO2007012539A2 (en) 2005-07-26 2006-06-29 Pharmaceutical formulation of nitrooxyderivatives of nsaids

Publications (1)

Publication Number Publication Date
ATE485033T1 true ATE485033T1 (de) 2010-11-15

Family

ID=37670077

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06777502T ATE485033T1 (de) 2005-07-26 2006-06-29 Pharmazeutische formulierung von nitrooxy- derivaten von nsar

Country Status (24)

Country Link
US (1) US8691869B2 (de)
EP (1) EP1906938B1 (de)
JP (1) JP5238499B2 (de)
KR (1) KR101342910B1 (de)
CN (1) CN101227896B (de)
AR (1) AR055094A1 (de)
AT (1) ATE485033T1 (de)
AU (1) AU2006274098B2 (de)
CA (1) CA2616508C (de)
CY (1) CY1112023T1 (de)
DE (1) DE602006017701D1 (de)
DK (1) DK1906938T3 (de)
ES (1) ES2354278T3 (de)
HR (1) HRP20110025T1 (de)
IL (1) IL188253A0 (de)
MX (1) MX2008001213A (de)
NO (1) NO20080983L (de)
NZ (1) NZ564589A (de)
PL (1) PL1906938T3 (de)
PT (1) PT1906938E (de)
RU (1) RU2406482C2 (de)
SI (1) SI1906938T1 (de)
WO (1) WO2007012539A2 (de)
ZA (1) ZA200801009B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011209757A (ja) * 2011-07-06 2011-10-20 Rohto Pharmaceutical Co Ltd コンタクトレンズケア方法及び組成物
EP2744487B1 (de) * 2011-08-15 2016-10-05 Research Foundation Of The City University Of New York No- und h2s-freisetzende verbindungen
WO2013130625A1 (en) * 2012-02-27 2013-09-06 Basil Rigas Phospho-ester derivatives and uses thereof
RU2657803C1 (ru) * 2017-03-21 2018-06-15 федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный университет" Средство, обладающее противовоспалительным и анальгезирующим действием

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997033568A1 (en) 1996-03-12 1997-09-18 Novartis Ag Filled gelatin capsules having a reduced degree of cross-linking
TWI243672B (en) * 1999-06-01 2005-11-21 Astrazeneca Ab New use of compounds as antibacterial agents
SE0000774D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
SE0000773D0 (sv) * 2000-03-08 2000-03-08 Astrazeneca Ab New formulation
US8895059B2 (en) * 2002-06-05 2014-11-25 Ivax Pharmaceuticals S.R.O. Reduction of cross-linking gelatin in gelatin capsules
CA2494358A1 (en) * 2002-07-31 2004-02-05 Pharmacia Corporation Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage

Also Published As

Publication number Publication date
EP1906938B1 (de) 2010-10-20
RU2008104505A (ru) 2009-09-10
IL188253A0 (en) 2008-04-13
EP1906938A2 (de) 2008-04-09
WO2007012539A3 (en) 2007-04-19
PL1906938T3 (pl) 2011-05-31
ZA200801009B (en) 2008-11-26
AU2006274098A1 (en) 2007-02-01
MX2008001213A (es) 2008-03-24
CN101227896A (zh) 2008-07-23
JP2009502850A (ja) 2009-01-29
WO2007012539A2 (en) 2007-02-01
DK1906938T3 (da) 2011-02-07
NZ564589A (en) 2010-01-29
SI1906938T1 (sl) 2011-02-28
AU2006274098B2 (en) 2012-02-09
US8691869B2 (en) 2014-04-08
KR101342910B1 (ko) 2013-12-19
ES2354278T3 (es) 2011-03-11
CN101227896B (zh) 2013-02-06
HRP20110025T1 (hr) 2011-03-31
RU2406482C2 (ru) 2010-12-20
AR055094A1 (es) 2007-08-08
US20090203759A1 (en) 2009-08-13
CA2616508A1 (en) 2007-02-01
NO20080983L (no) 2008-02-25
KR20080028412A (ko) 2008-03-31
DE602006017701D1 (de) 2010-12-02
CY1112023T1 (el) 2015-11-04
JP5238499B2 (ja) 2013-07-17
CA2616508C (en) 2015-02-24
HK1120414A1 (en) 2009-04-03
PT1906938E (pt) 2011-01-17

Similar Documents

Publication Publication Date Title
ATE551989T1 (de) Kleinmolekülige heilmittelformulierung mit verzögerter freisetzung
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
NO20075628L (no) Farmasøytiske formuleringer
ITMI20050728A1 (it) Formulazione innovativa
ATE531358T1 (de) Selbsterhaltende wässrige pharmazeutische zusammensetzungen
IL188732A (en) Use of ibuprofen and famotidine in the preparation of medicaments
HUS1400051I1 (hu) Lurazidont tartalmazó gyógyászati készítmény
BRPI0511900A (pt) composições farmacêuticas
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
ATE466570T1 (de) Wässrige hfsh-formulierung
PT1850664E (pt) Formulação de cápsulas
DK1928427T3 (da) Hidtil ukendt dosisformulering
DK1957073T3 (da) Lægemiddel
DK1868586T3 (da) Antiinflammatorisk formulering
EP1871347A4 (de) Pharmazeutische zusammensetzung
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
BRPI0611748A2 (pt) composto, composição farmacêutica, e, uso de uma composição farmacêutica
ATE485033T1 (de) Pharmazeutische formulierung von nitrooxy- derivaten von nsar
DK2918286T3 (da) En farmaceutisk formulering
BRPI0617943A2 (pt) composto farmacêutico e uso de um composto farmacêutico
DK1784174T3 (da) Famaceutisk sammensætning omfattende gabapentin
ITMI20040943A1 (it) Composizione farmaceutica cicatrizzante
EP1845944A4 (de) Pharmazeutische zusammensetzungen
ATE387189T1 (de) Sprühgetrocknete pharmazeutische zusammensetzungen
EP1747205A4 (de) Pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1906938

Country of ref document: EP